American biopharmaceutical company Gilead has announced steps to expand the availability of Remdesivir, a key therapeutic medicine used in the treatment of Covid-19 patients in India

 "The recent surge of Covid-19 cases in India is having a devastating impact on communities and has created unprecedented pressure on health systems,” Johanna Mercier, chief commercial officer of Gilead Sciences said on Monday.